ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Granite Investment Partners LLC

Granite Investment Partners LLC cut its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 102,087 shares of the medical instruments supplier's stock after selling 2,215 shares during the quarter. Granite Investment Partners LLC owned about 0.42% of ICU Medical worth $15,841,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical in the fourth quarter valued at approximately $33,000. Murphy & Mullick Capital Management Corp purchased a new stake in ICU Medical in the 4th quarter valued at $52,000. Venturi Wealth Management LLC increased its stake in shares of ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in shares of ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 300 shares during the period. Finally, Sterling Capital Management LLC boosted its position in shares of ICU Medical by 813.5% during the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after acquiring an additional 602 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Trading Down 0.3 %

Shares of NASDAQ ICUI traded down $0.47 during trading on Friday, reaching $138.67. The stock had a trading volume of 205,209 shares, compared to its average volume of 269,897. The business's 50-day moving average price is $146.73 and its 200-day moving average price is $160.03. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a market cap of $3.40 billion, a P/E ratio of -30.34 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday. Raymond James set a $97.00 target price on ICU Medical in a research note on Wednesday, March 12th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, ICU Medical presently has a consensus rating of "Buy" and an average price target of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.